Stroke 27 , 20592063 (1996)
Can GLP-1 drugs treat Alzheimers or Parkinsons disease
Chemically, its the same molecule , a GLP-1 receptor agonist that slows gastric emptying, suppresses appetite via hypothalamic signaling, and improves insulin secretion in a glucose-dependent manner
Garrido D, Kim JH, German JB, Raybould HE, Mills DA (2011) Oligosaccharide binding proteins from Bifidobacterium longum subsp
Kouichi Tamura has received honoraria/lecture fee from AstraZeneca, Novartes, Bayer, Otsuka Pharmaceutical, Boehringer Ingelheim, Fuji Pharma, Kyowa Kirin, Ono Pharmaceutical, Sanwa Kagaku, Mochida Pharmaceutical, Kowa, Eli Lilly, Novo Nordisk, commissioned clinical trials, contract research and joint research funding: AstraZeneca, Bayer, Novartis, Chinook, Otsuka Medical Devices, Novo Nordisk, Terumo, Variatris, and Kowa, and, Scholarship donations: Otsuka Pharmaceutical, Bayer, Mochida Pharmaceutical, and Boehringer Ingelheim
Instead, they offer one data point that helps your provider contextualize your clinical presentation and expected titration pace